| Literature DB >> 29730154 |
Benjamin Theek1, Maike Baues2, Felix Gremse2, Robert Pola3, Michal Pechar3, Inka Negwer4, Kaloian Koynov4, Benjamin Weber5, Matthias Barz5, Willi Jahnen-Dechent6, Gert Storm7, Fabian Kiessling2, Twan Lammers8.
Abstract
Tumors are characterized by leaky blood vessels, and by an abnormal and heterogeneous vascular network. These pathophysiological characteristics contribute to the enhanced permeability and retention (EPR) effect, which is one of the key rationales for developing tumor-targeted drug delivery systems. Vessel abnormality and heterogeneity, however, which typically result from excessive pro-angiogenic signaling, can also hinder efficient drug delivery to and into tumors. Using histidine-rich glycoprotein (HRG) knockout and wild type mice, and HRG-overexpressing and normal t241 fibrosarcoma cells, we evaluated the effect of genetically induced and macrophage-mediated vascular normalization on the tumor accumulation and penetration of 10-20 nm-sized polymeric drug carriers based on poly(N-(2-hydroxypropyl)methacrylamide). Multimodal and multiscale optical imaging was employed to show that normalizing the tumor vasculature improves the accumulation of fluorophore-labeled polymers in tumors, and promotes their penetration out of tumor blood vessels deep into the interstitium.Entities:
Keywords: Drug delivery; EPR; HRG; Nanomedicine; Tumor targeting; Vascular normalization; pHPMA
Mesh:
Substances:
Year: 2018 PMID: 29730154 PMCID: PMC6130770 DOI: 10.1016/j.jconrel.2018.05.002
Source DB: PubMed Journal: J Control Release ISSN: 0168-3659 Impact factor: 9.776